Research And Option Agreement Sample Contracts

Dimension Therapeutics, Inc. – Sponsored Research and Option Agreement (March 9th, 2017)

This Sponsored Research Agreement ("Agreement"), effective as of January 1, 2015 (the "Effective Date") is made by and between The Trustees of the University of Pennsylvania, a Pennsylvania nonprofit corporation ("Institution"), with offices located at The Penn Center for Innovation, 3160 Chestnut St., Suite 200, Philadelphia, PA 19104, and Dimension Therapeutics, Inc., a corporation organized under the laws of Delaware ("Sponsor"), having a place of business at 840 Memorial Drive, Cambridge, MA, 02139.

Dimension Therapeutics, Inc. – Sponsored Research and Option Agreement (October 13th, 2015)

This Sponsored Research Agreement (Agreement), effective as of January 1, 2015 (the Effective Date) is made by and between The Trustees of the University of Pennsylvania, a Pennsylvania nonprofit corporation (Institution), with offices located at The Penn Center for Innovation, 3160 Chestnut St., Suite 200, Philadelphia, PA 19104, and Dimension Therapeutics, Inc., a corporation organized under the laws of Delaware (Sponsor), having a place of business at 840 Memorial Drive, Cambridge, MA, 02139.

Dimension Therapeutics, Inc. – Sponsored Research and Option Agreement (July 17th, 2015)

This Sponsored Research Agreement (Agreement), effective as of January 1, 2015 (the Effective Date) is made by and between The Trustees of the University of Pennsylvania, a Pennsylvania nonprofit corporation (Institution), with offices located at The Penn Center for Innovation, 3160 Chestnut St., Suite 200, Philadelphia, PA 19104, and Dimension Therapeutics, Inc., a corporation organized under the laws of Delaware (Sponsor), having a place of business at 840 Memorial Drive, Cambridge, MA, 02139.

Xenon Pharmaceuticals Inc. – EXCLUSIVE COLLABORATIVE RESEARCH AND OPTION AGREEMENT by and Between MERCK SHARP & DOHME RESEARCH LTD. And XENON PHARMACEUTICALS INC. (October 6th, 2014)

This Exclusive Collaborative Research and Option Agreement (the Agreement) is effective as of June 10, 2009 (the Effective Date) and is entered into by and between MERCK SHARP & DOHME RESEARCH LTD., a company organized and existing under the laws of Bermuda (Merck), and XENON PHARMACEUTICALS INC., a corporation organized and existing under the laws of Canada (Xenon).